Novel immune checkpoint blocker approved for the treatment of advanced melanoma.

ABSTRACT:

SUBMITTER: Galluzzi L 

PROVIDER: S-EPMC4292712 | biostudies-literature | 2014 Nov

REPOSITORIES: biostudies-literature